Applied Genetic Technologies (AGTC) Tops Q4 EPS by 8c

September 12, 2016 4:23 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $12.93 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment